Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Allergol Immunopathol (Madr) ; 49(6): 56-59, 2021.
Article in English | MEDLINE | ID: mdl-34761657

ABSTRACT

Food allergy is rising rapidly among children, and allergy to nuts is one of the most prevalent allergies among them. The category "nuts and seeds" include several plant foods from different botanical families, very different from each other. It is not uncommon to detect co-sensitization to different nuts. However, true co-allergy is less frequent. Up to 80% of patients with positive skin prick tests or specific IgE without true history of reaction who avoid certain nuts, might tolerate them in an Oral Food Challenge (OFC). Although molecular diagnostic techniques help to improve nut allergy diagnosis, OFC still remains the gold standard. For this reason, after reviewing the current bibliography and the recommendations of different allergy societies on standardization of open OFC, the Food Allergy Committee of the Spanish Society of Pediatric Allergy, Asthma and Clinical Immunology (SEICAP) food allergy working group proposed a unified protocol to undertake these OFC, which include preliminary recommendations, unification of total dose, number of doses and interval between doses. Additionally, this group offers an interactive table to facilitate calculation of doses specific to each nut under study.


Subject(s)
Food Hypersensitivity , Nut Hypersensitivity , Allergens , Child , Food Hypersensitivity/diagnosis , Humans , Nut Hypersensitivity/diagnosis , Nuts/immunology , Skin Tests
2.
Allergol Immunopathol (Madr) ; 49(3): 169-172, 2021.
Article in English | MEDLINE | ID: mdl-33938203

ABSTRACT

BACKGROUND AND OBJECTIVES: Based on previous studies revealing acid-suppression medication as a risk factor for food allergy tolerance induction, we aimed to establish the importance of those findings in patients undergoing oral immunotherapy (OIT). MATERIALS AND METHODS, RESULTS: We describe a case series of four patients who underwent milk OIT with a concomitant use of proton pump inhibitor (PPI) medication and who developed anaphylaxis after a known, previously tolerated dose of milk. CONCLUSIONS: PPIs may act as a cofactor in patients undergoing OIT, triggering adverse reactions, irrespective of the PPI used or the dosage. It would be necessary to separate the administration of drug from food intake.Since OIT is a new form of treatment, long-term adverse events arising from PPI treatment and other possible triggers are still uncertain. Consequently, monitoring of patient must be prolonged over time. Additional investigations on the influence of different drugs in OIT maintenance phase are required.


Subject(s)
Anaphylaxis/etiology , Desensitization, Immunologic/methods , Eosinophilic Esophagitis/therapy , Food Hypersensitivity/therapy , Gastritis/therapy , Proton Pump Inhibitors/adverse effects , Animals , Child , Desensitization, Immunologic/adverse effects , Female , Humans , Male , Milk
SELECTION OF CITATIONS
SEARCH DETAIL
...